Suppr超能文献

急诊就诊成年人中通过未增强胸部 CT 确定的肝脂肪变性患病率。

Prevalence of Hepatic Steatosis in Adults Presenting to the Emergency Department Identified by Unenhanced Chest CT.

机构信息

Russell H. Morgan Department of Radiology and Radiological Science, The Johns Hopkins University School of Medicine, Baltimore, MD.

Russell H. Morgan Department of Radiology and Radiological Science, The Johns Hopkins University School of Medicine, Baltimore, MD.

出版信息

Curr Probl Diagn Radiol. 2023 Jan-Feb;52(1):35-40. doi: 10.1067/j.cpradiol.2022.07.014. Epub 2022 Jul 30.

Abstract

This study aimed to investigate the prevalence of hepatic steatosis in racially diverse adults presenting to the emergency department at a tertiary healthcare system in the United States using attenuation values on unenhanced computed tomography (CT) as the reference standard. The utility of known risk factors for predicting the presence of hepatic steatosis was assessed. Additionally, reporting of hepatic steatosis in original radiology reports was evaluated. For 381 consecutive adults (193 women and 188 men; mean age 55.2 ± 17.2 years), hepatic (left medial, left lateral, right anterior, and right posterior) and splenic (upper, middle, and lower) CT attenuation values (Hounsfield units) were obtained by drawing a 1 cm region of interest on unenhanced chest CT obtained in the emergency department for any indication. Multiple attenuation criteria for steatosis, including liver thresholds and liver and spleen attenuation comparison, were applied. Relevant clinical risk factors were recorded and compared against a liver/ spleen attenuation ratio of ≤ 1.1 to include all individuals with steatosis in the analysis. Mean liver attenuation was 59.5 ± 10.4 HU. The prevalence of hepatic steatosis ranged from 5-35.4% depending on the CT attenuation criterion used (5%, liver attenuation ≤ 40 HU; 6.3%, liver attenuation ≤ (spleen attenuation - 10 HU); 16.8%, liver attenuation ≤ spleen attenuation; 34.1%, liver attenuation ≤ (spleen attenuation + 5 HU); 35.4%, liver attenuation/ spleen attenuation ≤ 1.1). The prevalence of hepatic steatosis was higher in males compared to females (P = 0.01, 42% vs 29%) and age 40-65 years when compared to the rest (P = 0.03, 43.5% vs 32.2%), but similar across different racial (P = 0.55), ethnic (P = 0.78) groups. Overweight status (body mass index >25) and hypertension were sensitive indicator for steatosis (sensitivity = 60.7% and 60.5%) but were highly nonspecific (specificity = 41.9% and 49.2%). Other clinical risk factors, such as diabetes, dyslipidemia, alcohol overuse, and hepatitis, were more specific (specificity = 62.2%-93.9%) but highly insensitive (sensitivity = 7.5%-40.3%). 63% (12/19) radiology reports mentioned the presence of moderate-to-severe hepatic steatosis but only 11.1% (15/135) of them mentioned the presence of mild hepatic steatosis. Unenhanced chest CT can be used to assess hepatic steatosis for individuals presenting to the emergency department and provide a non-invasive means for opportunistic screening.

摘要

本研究旨在使用美国一家三级医疗保健系统急诊就诊的种族多样化成年人的未增强 CT(CT)衰减值作为参考标准,调查肝脂肪变性的流行率。评估了已知危险因素预测肝脂肪变性存在的效用。此外,还评估了原始放射学报告中肝脂肪变性的报告情况。

对 381 名连续成年人(193 名女性和 188 名男性;平均年龄 55.2±17.2 岁),在急诊科因任何原因进行胸部 CT 平扫时,通过在肝(左内侧、左外侧、右前和右后)和脾(上、中、下)上画一个 1cm 的感兴趣区,获得肝脏和脾脏 CT 衰减值(亨氏单位)。应用了多种肝脂肪变性的衰减标准,包括肝脏阈值和肝脏与脾脏衰减比较。记录了相关的临床危险因素,并与肝脏/脾脏衰减比≤1.1 进行比较,以便在分析中包括所有有肝脂肪变性的个体。平均肝脏衰减值为 59.5±10.4 HU。根据使用的 CT 衰减标准,肝脂肪变性的患病率范围为 5%-35.4%(5%,肝脏衰减值≤40 HU;6.3%,肝脏衰减值≤(脾脏衰减值-10 HU);16.8%,肝脏衰减值≤脾脏衰减值;34.1%,肝脏衰减值≤(脾脏衰减值+5 HU);35.4%,肝脏衰减值/脾脏衰减值≤1.1)。与女性相比,男性的肝脂肪变性患病率更高(P=0.01,42% vs 29%),与 40-65 岁的人群相比,患病率更高(P=0.03,43.5% vs 32.2%),但在不同种族(P=0.55)和民族(P=0.78)人群中无显著差异。超重状态(BMI>25)和高血压是肝脂肪变性的敏感指标(敏感性分别为 60.7%和 60.5%),但特异性较低(分别为 41.9%和 49.2%)。其他临床危险因素,如糖尿病、血脂异常、酒精滥用和肝炎,具有较高的特异性(特异性为 62.2%-93.9%),但敏感性较低(敏感性为 7.5%-40.3%)。63%(12/19)的放射学报告提到了中重度肝脂肪变性的存在,但只有 11.1%(15/135)的报告提到了轻度肝脂肪变性的存在。未增强的胸部 CT 可用于评估急诊就诊患者的肝脂肪变性,并提供一种非侵入性的机会性筛查方法。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验